Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Long Term Persistence of IgE Anti-Influenza Virus Antibodies in Pediatric and Adult Serum Post Vaccination with Influenza Virus Vaccine. | Int. J. Med. Sci. 2011 8 239 International Journal of Medical Sciences 2011 8 3 239-244 Research Paper Long Term Persistence of IgE Anti-Influenza Virus Antibodies in Pediatric and Adult Serum Post Vaccination with Influenza Virus Vaccine Tamar A. Smith-Norowitz1 5 x Darrin Wong2 Melanie Kusonruksa2 Kevin B. Norowitz1 5 Rauno Joks3 5 Helen G. Durkin2 5 Martin H. Bluth4 1. Departments of Pediatrics . Downstate Medical Center Brooklyn New York 11203 USA 2. Departments of Pathology . Downstate Medical Center Brooklyn New York 11203 USA 3. Departments of Medicine . Downstate Medical Center Brooklyn New York 11203 USA 4. Department of Pathology Wayne State University School of Medicine Detroit Michigan 48201 USA 5. Center for Allergy and Asthma Research . Downstate Medical Center Brooklyn New York 11203 USA H Corresponding author Tamar A. Smith-Norowitz . SUNY Downstate Medical Ctr. Dept of Pediatrics Box 49 450 Clarkson Ave. Brooklyn New York 11203 718 270-1295 718 270-3289 fax Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License http licenses by-nc-nd . Reproduction is permitted for personal noncommercial use provided that the article is in whole unmodified and properly cited. Received Accepted Published Abstract The production of IgE specific to different viruses HIV- 1 Parvovirus B 19 Parainfluenza virus Varicella Zoster Virus and the ability of IgE anti-HIV- 1 to suppress HIV- 1 production in vitro strongly suggest an important role for IgE and or anti viral specific IgE in viral pathogenesis. Nevertheless the presence and persistence of IgE anti-Influenza virus antibodies has not been studied. Total serum IgE and specific IgE and IgG anti-Influenza virus antibodies were studied in children N 3 m f 14-16 y o and adults N 3 m f 41-49 y o 2-20 months after vaccination with
